Effect of Fingolimod in acute ischemic stroke

Phase 2

Recruiting

• Conditions: I63.00; Cerebral infarction due to thrombosis of unspecified precerebral artery; Acute Ischemic Stroke.

• Registration Number: IRCT20220423054619N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Acute onset focal neurologic deficit
Age more then 18 years
referring to hospital in less than 4.5 hours

Exclusion Criteria

Age more than 80
History of moderate or severe cardiovascular condition
History of prior probable retinal problems
Active viral or bacterial infection
Suspicion of other neurologic conditions than CVA
No existing hyperdense lesion in entry CT scan consisting with hemorrhagic lesion

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ational Institutes of Health Stroke Scale. Timepoint: At entrance , first month and 6th month after intervention. Method of measurement: Neurologic examination of neurologist.;The Modified Rankin Scale (mRS) for neurologic disability. Timepoint: Neurologic examination of neurologist. Method of measurement: The Modified Rankin Scale (mRS) for neurologic disability.

Secondary Outcome Measures

Name	Time	Method
Hemorrhagic changes of stroke territory. Timepoint: 3th and 7th day after stroke. Method of measurement: CT scan by neurologist.